cytarabine has been researched along with Pseudotumor Cerebri in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Boufrikha, W; Boughammoura, A; Laatiri, MA; Lakhal, S; Rakez, R | 1 |
| Croxson, G; Halmagyi, GM; McCluskey, P; O'Connor, L | 1 |
| Catalano, L; Frigeri, F; Luciano, L; Notaro, R; Pane, F; Rotoli, B; Salvatore, F; Santoro, LE; Selleri, C | 1 |
| Fort, JA; Smith, LD | 1 |
| Cortes, J; Freireich, EJ; Gajewski, J; Giles, FJ; Kantarjian, HM; Koller, C; Kornblau, S; O'Brien, S; Rios, MB; Sacchi, S; Talpaz, M | 1 |
| Dabadghao, S; Melinkeri, SR; Mishra, SK | 1 |
| Evers, JP; Jacobson, RJ; Pincus, J; Zwiebel, JA | 1 |
1 trial(s) available for cytarabine and Pseudotumor Cerebri
| Article | Year |
|---|---|
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Female; Femur Head Necrosis; Humans; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Life Tables; Male; Middle Aged; Paranoid Disorders; Pilot Projects; Pseudotumor Cerebri; Pulmonary Edema; Red-Cell Aplasia, Pure; Remission Induction; Survival Analysis; Syncope; Treatment Outcome; Tretinoin | 1999 |
6 other study(ies) available for cytarabine and Pseudotumor Cerebri
| Article | Year |
|---|---|
The diagnostic dilemma of idiopathic intracranial hypertension in a child with acute lymphoblastic leukemia: COVID-19 or cytosine arabinoside?
Topics: Child; COVID-19; Cytarabine; Headache; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudotumor Cerebri; SARS-CoV-2 | 2022 |
A 43-year-old woman presenting with subacute, bilateral, sequential facial nerve palsies, then developing pseudotumour cerebri.
Topics: Adult; Anticoagulants; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bell Palsy; Chemoradiotherapy; Chronic Disease; Cyclophosphamide; Cytarabine; Delayed Diagnosis; Dexamethasone; Doxorubicin; Female; Humans; Intracranial Hypertension; Lymphoma, B-Cell; Magnetic Resonance Imaging; Mastoid; Methotrexate; Optic Atrophy; Otitis Media, Suppurative; Papilledema; Pseudotumor Cerebri; Sinus Thrombosis, Intracranial; Treatment Outcome; Vincristine; Vision, Low | 2015 |
All-trans-retinoic acid (ATRA) responsive skin relapses of acute promyelocytic leukaemia followed by ATRA-induced pseudotumour cerebri.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Blotting, Southern; Cytarabine; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Molecular Sequence Data; Polymerase Chain Reaction; Pseudotumor Cerebri; Skin Neoplasms; Tretinoin | 1996 |
Pseudotumor cerebri secondary to intermediate-dose cytarabine HCl.
Topics: Acetazolamide; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Child; Cytarabine; Diuretics; Humans; Leukemia, Myeloid, Acute; Male; Prednisone; Pseudotumor Cerebri | 1999 |
Benign thymic hyperplasia after chemotherapy for acute myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Female; Humans; Hyperplasia; Leukemia, Promyelocytic, Acute; Pseudotumor Cerebri; Radiography; Sweet Syndrome; Thymus Gland; Tretinoin | 2001 |
Pseudotumour cerebri following high-dose cytosine arabinoside.
Topics: Adult; Cytarabine; Drug Administration Schedule; Female; Humans; Pseudotumor Cerebri | 1992 |